Drug prevention

Aminoguanidine has been shown to prevent the formation of AGEs (Brownlee et al., 1986) and treatment with this drug prevents retinal pericyte loss in STZ-induced diabetic rats (Hammes et al., 1990). More recendy, functional and structural impairments in peripheral nerves are ameliorated by aminoguanidine in male Wistar rats (Yagihashi et al., 1992). These data surest that inhibitors of non-enzymatic glycosyiation may have a future role in the treatment of diabetic complications. 

Greenberg, Roger P., Reflections on the Emperor s New Drugs , Prevention Treatment, no. 27 (2002) http //www.joumals.apa.org/prevention/ volumes / pre0050027c.html... 

Carbonic anhydrase inhibitors such as acetazolamide act in the proximal tubule. These drugs prevent the formation of H+ ions, which are transported out of the tubular epithelial cell in exchange for Na+ ions. These agents have limited clinical usefulness because they result in development of metabolic acidosis. 

There is no evidence that inhibiting gastric acid secretion by antisecretory drugs prevents exacerbations of abdominal pain, but they may be used to prevent stress-related mucosal bleeding. 

Drugstory.org. Information about Drug Prevention and Treatment,... 

In addition to being used as antianginal and antiarrhythmic agents, calcium channel blockers are used to treat weak and moderate hypertension. These drugs prevent calcium ions from entering into the smooth muscle cells of peripheral vessels, and they cause relaxation of peripheral vessels, which leads to lowering of arterial blood pressure. In clinically used doses, calcium channel blockers relax smooth musculature of arteries and have little effect on veins. In doses that relax smooth musculature, calcium channel blockers have relatively little effect on cardiac contractility. 

The basis for the antihypertensive activity of the ganglionic blockers lies in their ability to block transmission through autonomic ganglia (Fig. 20.2C). This action, which results in a decrease in the number of impulses passing down the postganglionic sympathetic (and parasympathetic) nerves, decreases vascular tone, cardiac output, and blood pressure. These drugs prevent the interaction of acetylcholine (the transmitter of the preganglionic autonomic nerves) with the nicotinic receptors on postsynaptic neuronal membranes of both the sympathetic and parasympathetic nervous systems. 

Procaine and the other local anaesthetic drugs prevent the generation and the conduction of the nerve impulses. Their main site of action is the cell membrane, since conduction block can be demonstrated in giant axons from which the axoplasm has been removed [25]. 

Receptors are proteins usually embedded in the cell s membrane. A neurotransmitter such as dopamine docks at its receptor, activating it and initiating some kind of response in the postsynaptic cell. The response depends on the type of receptor, and there are a number of different ones for most neurotransmitters. Researchers have found five dopamine receptors the one affected by chlorpromazine and similar drugs is known as D. These drugs prevent dopamine from activating the receptor. 

The central facet of many drug prevention strategies is that... 

Drugs preventing the entry of virus into the human ceii... 

Finally, the toxicity of some effective drugs prevents their use at maximally effective dosage. The widespread indiscriminate use of 3 blockers has been criticized because several large clinical trials indicate that some members of the group, eg, metoprolol and carvedilol, have a greater benefit than others, eg, atenolol. However, all 3 blockers appear to have similar benefits in reducing mortality after myocardial infarction, so these drugs are particularly indicated in patients with an infarct and hypertension. 

Demand To move beyond containment and to reduce the risk of drugs to public health and public security, more attention must be paid to drug prevention and treatment. While much of this 2007Report looks at world drug trends in terms of cultivation, production, seizures and prices, these are just the symptoms. If the drug problem is to be reduced in the longer term, there must be more intervention at the level of consumption, to treat the problem at its source - the drug users. 

The formation of the neurite-like processes appears to be dependent on assembly of microtubules as colchicine and Colcemid, antimicrotubule drugs, prevented shape changes in the presence of butyrate (2,8). The amount of tubulin per cell did not change when HeLa were treated with butyrate (R.C.Henneberry, unpublished observations). The role of microtubule assembly was further explored with a calcium ionophore which alters intracellular calcium levels and thus promotes microtubule depolymerization. 

Mechanism of Action. As indicated, anakinra is an antagonist (blocker) that is specific for the interleukin-1 receptor found on joint tissues, other tissues, and organs.23 By blocking this receptor, the drug prevents interleukin-1 from binding to this receptor and exerting destructive effects on joint tissues. 

Sucralfate [Carafate, Sulcrate). Sucralfate is a disaccharide that exerts a cytoprotective effect on the stomach mucosa.26,37 Although the exact mechanism is unclear, sucralfate may form a protective gel within the stomach that adheres to ulcers and shields them from the contents of the stomach. The protective barrier formed by the drug prevents further erosion and permits healing of duodenal and gastric ulcers. Sucralfate is well tolerated, although constipation may occur in some patients. 

---